Donate

Play Live Radio

Next Up:

0:00

0:00 0:00

Available On Air Stations

SC Public Radio's statewide network is experiencing intermittent outages and programming issues due to ongoing infrastructure upgrades. Our team is working to keep these disruptions to a minimum and to resolve issues that do arise. During broadcast outages, streaming on this site, the SCETV App, the NPR App, and smart speakers will remain unaffected.

Moderna and Merck's mRNA vaccine reduces melanoma recurrence by 42%

WBUR

Published October 27, 2026 at 12:01 PM EDT

Facebook
Twitter
LinkedIn
Email

Moderna and Merck recently released remarkable new results of their personalized cancer vaccine.

Here & Now‘s Scott Tong speaks with Matthew Herper, a senior writer at STAT, the health and science publication.

This article was originally published on WBUR.org.